News Daily News New Revascularization Guidelines Plug Radial Access, Staged PCI, and Shorter DAPT Michael O'Riordan December 09, 2021
News Daily News CAC Tests Boost CAD Prediction in Younger Patients at Risk for ASCVD Yael L. Maxwell October 14, 2021
News Conference News ESC 2021 New ESC Prevention Guidelines Focus on Tailored, Escalating Therapy Michael O'Riordan September 03, 2021
News Daily News Empagliflozin Succeeds in HFpEF: EMPEROR-Preserved Top-line Results Todd Neale July 06, 2021
News Daily News Sleep Apnea Awareness, Treatment May Improve Some CVD Outcomes: AHA L.A. McKeown June 23, 2021
News Daily News Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA Michael O'Riordan April 26, 2021
News Daily News Big Drops in LDL Cholesterol With Inclisiran, but US Clinicians Still Await Drug’s Approval Michael O'Riordan March 03, 2021
News Daily News Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD Michael O'Riordan January 25, 2021
News Features The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations L.A. McKeown December 24, 2020
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News Plaque Burden, Not Coronary Stenosis, Linked to Future Events in Stable CAD Michael O'Riordan December 07, 2020
News Conference News AHA 2020 No Doctor? No Problem: Remote, Pharmacist-Led Intervention Cuts CVD Risk Michael O'Riordan November 19, 2020
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020
News Daily News Diabetes Influences Relative Effects of Ticagrelor, Prasugrel in ACS: ISAR-REACT 5 Todd Neale October 09, 2020
News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Daily News VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks Michael O'Riordan September 24, 2020
News Conference News ESC 2020 EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF Michael O'Riordan August 28, 2020
News Daily News Obesity’s Role in COVID-19 Deaths: ‘Profound’ and Independent of CVD Shelley Wood August 14, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020